Jasper Therapeutics, Inc.JJ

Jasper Therapeutics, Inc.

0.1589USDR
+0.0120+8.17%
Last update at Feb 18, 20:31 GMT
USD
No trades
See on Supercharts
Market capitalization
‪89.86 M‬USD
−4.7463USD
‪−64.47 M‬USD
0.00USD
‪11.16 M‬
Beta (1Y)
2.11

About Jasper Therapeutics, Inc.


CEO
Ronald A. Martell
Headquarters
Redwood City
Founded
2018
FIGI
BBG00RBFC714
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Performance
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−20.00 M‬‬
‪‪−15.00 M‬‬
‪‪−10.00 M‬‬
‪‪−5.00 M‬‬
‪0.00‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−20.00 M‬‬
‪‪−15.00 M‬‬
‪‪−10.00 M‬‬
‪‪−5.00 M‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−20.00 M‬‬
‪‪−15.00 M‬‬
‪‪−10.00 M‬‬
‪‪−5.00 M‬‬
‪0.00‬
Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−40.00 M‬‬
‪0.00‬
‪‪40.00 M‬‬
‪‪80.00 M‬‬
‪‪120.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Mar 11, 2025
2021
2022
2023
2024
‪−28.00‬
‪−21.00‬
‪−14.00‬
‪−7.00‬
‪0.00‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

Displays a symbol's price movements over previous years to identify recurring trends.